1995
DOI: 10.1016/0165-2478(95)00041-3
|View full text |Cite
|
Sign up to set email alerts
|

Enzymatic activity of DPIVCD26 is involved in PMA-induced hyperphosphorylation of p56lck

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

1998
1998
2004
2004

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 18 publications
0
6
0
Order By: Relevance
“…Indeed, it has been specifically demonstrated that DPPIV inhibitors affect tyrosine phosphorylation of multiple proteins in lymphocytes (23,24). Similarly, we found that the DPPIV inhibitor P32/98 decreased tyrosine phosphorylation of a high apparent molecular mass protein (Ͼ212 kDa) that coprecipitates with DPPIV, indicating a role for DPPIV in regulating tyrosine kinase signaling in OKP cells.…”
Section: Discussionmentioning
confidence: 48%
See 1 more Smart Citation
“…Indeed, it has been specifically demonstrated that DPPIV inhibitors affect tyrosine phosphorylation of multiple proteins in lymphocytes (23,24). Similarly, we found that the DPPIV inhibitor P32/98 decreased tyrosine phosphorylation of a high apparent molecular mass protein (Ͼ212 kDa) that coprecipitates with DPPIV, indicating a role for DPPIV in regulating tyrosine kinase signaling in OKP cells.…”
Section: Discussionmentioning
confidence: 48%
“…It is therefore of interest that DPPIV (CD26) regulation of cell proliferation and cytokine production in lymphocytes has been associated with changes in tyrosine kinase signaling (20,(22)(23)(24)36). Indeed, it has been specifically demonstrated that DPPIV inhibitors affect tyrosine phosphorylation of multiple proteins in lymphocytes (23,24).…”
Section: Discussionmentioning
confidence: 99%
“…DP IV/CD26 lacks an intracellular domain required for intracellular signalling. However, inhibition of DP IV activity suppresses early phosphorylation events in T‐cell activation in a dose‐dependent and reversible manner, as shown for hyperphosphorylation of p56lck [25]. In fact, it has been proposed that DP IV/CD26 associates with CD45 [20] which, in turn, regulates p56lck [26].…”
Section: Discussionmentioning
confidence: 99%
“…Some authors have described that small synthetic inhibitors of DPP IV impair lectin and antigen stimulation of peripheral blood mononuclear cells (PBMC) and other lymphocyte cell types [22]. A possible mechanism for this effect might be the inhibition of the hyperphosphorylation of the tyrosine kinase p56lck, a substrate of CD45, induced by DPP IV inhibitors [23], but the high concentrations of inhibitor required make such results questionable. The use of cell clones expressing a mutated, catalytically inactive, form of CD26 also gave contradictory results in two different cell lines, Jurkat [24] and BW2 [25].…”
mentioning
confidence: 99%